Talat Imran
2021
In 2021, Talat Imran earned a total compensation of $11.8M as Chief Executive Officer at Rani Therapeutics Holdings.
Compensation breakdown
Non-Equity Incentive Plan | $375,000 |
---|---|
Option Awards | $10,999,490 |
Salary | $408,333 |
Total | $11,782,823 |
Imran received $11M in option awards, accounting for 93% of the total pay in 2021.
Imran also received $375K in non-equity incentive plan and $408.3K in salary.
Rankings
In 2021, Talat Imran's compensation ranked 793rd out of 12,415 executives tracked by ExecPay. In other words, Imran earned more than 93.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 793 | 94th |
Manufacturing | 260 | 95th |
Chemicals And Allied Products | 86 | 96th |
Drugs | 73 | 97th |
Pharmaceutical Preparations | 46 | 97th |
Imran's colleagues
We found three more compensation records of executives who worked with Talat Imran at Rani Therapeutics Holdings in 2021.